FinnCap Reiterates “Corporate” Rating for Omega Diagnostics Group Plc (ODX)
Omega Diagnostics Group Plc (LON:ODX)‘s stock had its “corporate” rating reiterated by FinnCap in a report released on Tuesday. They currently have a GBX 30 ($0.39) target price on the stock. FinnCap’s price target points to a potential upside of 50.00% from the stock’s current price.
Shares of Omega Diagnostics Group Plc (LON:ODX) opened at GBX 19.55 ($0.26) on Tuesday. Omega Diagnostics Group Plc has a 52-week low of GBX 16.60 ($0.22) and a 52-week high of GBX 28.01 ($0.37).
Omega Diagnostics Group Plc Company Profile
Omega Diagnostics Group PLC is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.
Receive News & Stock Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related stocks with our FREE daily email newsletter.